Log In
person
Marinus Pharmaceuticals Inc
MRNS
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Seizure Treatment Drugs |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
19.56M | 63.12% |
| Seizure Treatment Drugs |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
11.37M | 36.70% |
| Seizure Treatment Drugs |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
0.05M | 0.17% |
| keyboard_arrow_down |
Seizure Treatment Drugs
Branded Pharmaceuticals (outsourced)
|
19.56M | 63.12% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Seizure Treatment Drugs
Pre-Revenue Pharmaceuticals
|
11.37M | 36.70% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Seizure Treatment Drugs
Pharmaceutical Patent Licensing
|
0.05M | 0.17% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||